tirzepatide and kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https tirzepatide chronic kidney disease trial

You can report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)

Additionally, the drugs have been called anti-obesity medications (AOMs) by some researchers who criticize the drugs for the possibility of severe side effects, the lack of research into long-term use and the possibility of triggering eating disorders in some patients

Source: Hwang, et al JAMA Health Forum March 14, 2025 Implications for employers: This modeled study suggests that employers should at least offer access to the two combination generic medications for obesity if budgets allow

Your stool may be loose, or you may feel queasy or nauseated for a day or two after

With Sculptra, these individuals can once again feel confident and proud of their appearance, showcasing the vibrant radiance that matches their newly acquired healthy lifestyle